Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial. [PDF]
Gokani K +11 more
europepmc +1 more source
Signatures of Trained Immunity Following mRNA Vaccination: Differences Between mRNA-1273 and BNT162b2. [PDF]
Kunc M +6 more
europepmc +1 more source
Myocarditis after COVID-19 mRNA vaccination in Norway: a nationwide validation study. [PDF]
Hagen BS +19 more
europepmc +1 more source
A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis. [PDF]
Tasaki A +11 more
europepmc +1 more source
Increased frequency and intensity of complicated migraine sans migraine after third BNT162b2 dose. [PDF]
Bombardi LM +3 more
europepmc +1 more source
To conclude that BNT162b2 does not worsen echocardiographic indices, well-powered multicenter studies are required. [PDF]
Finsterer J, Stollberger C.
europepmc +1 more source
Absence of autoantibodies linked to cancer and autoimmune disorders 26 weeks after BNT162b2 boosting in CoronaVac- primed individuals. [PDF]
Mat Yassim AS +6 more
europepmc +1 more source
GP Consultations for Venous Thromboembolism (VTE) After mRNA and Adeno-Vector-Based COVID-19 Vaccination-An Exposure-Anchored Self-Controlled Cohort Study Based on Primary Healthcare Data From the Netherlands. [PDF]
Jajou R +6 more
europepmc +1 more source
Comparative immunogenicity of COVID-19 vaccination in pregnant and non-pregnant women: a real-world cohort study. [PDF]
Aksoy A +7 more
europepmc +1 more source

